• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Hematology - Oncology Therapy

Hematology - Oncology Therapy

9780071637893
1 033,14 zł
981,48 zł Zniżka 51,66 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 981,48 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis

The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens

A  Doodys Core Title for 2021!

More than 500 treatment regimens

Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information that is critical to both office- and hospital-based practice of hematology and oncology.

Hematology-Oncology Therapy is divided into three sections::

Oncology::
Provides detailed information about the administration, supportive care, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approved chemotherapeutic regimens, drugs, and biological agents

Supportive Care, Drug Preparation, Complications, and Screening::
Consists of topics commonly encountered in clinical hematology-oncology practice, such as chemotherapy-induced nausea, oncologic emergencies, radiation complications, cancer pain management, cancer screening, and much more

Selected Hematologic Diseases::
Delivers an authoritative guide to therapy for the principal diseases in consultative hematology

This edition of Hematology-Oncology Therapy is enriched by the updating of all chapters as well as the addition of several new chapters; the new Expert Opinion, which provides recommendations and guidance from experts on the use of treatment regimens; and inclusion of the latest regimens.

Szczegóły produktu
49234
9780071637893
9780071637893

Opis

Rok wydania
2014
Numer wydania
2
Oprawa
twarda
Liczba stron
1888
Wymiary (mm)
224 x 282
Waga (g)
3590
  • Authors
    Preface
    SECTION I:: ONCOLOGY
    1. Adrenocortical Cancer, Peter F. Lebowitz and Tito Fojo
    2. Anal Cancer, David Ryan and Robert Mayer
    3. Biliary Tract Cancer:: Gallbladder Cancer and Cholangiocarcinoma, Verena Sagaster and Werner Scheithauer
    4. Bladder Cancer, Edwin M. Posadas and William L. Dabut
    5. Brain Cancer, Lyndon Kim and Howard Fine
    6. Breast Cancer, Peter F. Lebowitz and Jo Anne Zujewski
    7. Carcinoid Tumors, Eva Tiensuu Janson and Kjell Oberg
    8. Carcinoma of Unknown Primary, David Spigel and F. Anthony Greco
    9. Cervical Cancer, Deirdre OMahony and Peter Rose
    10. Colorectal Cancer, Gregory Leonard and Jean Grem
    11. Endometrial Cancer, Deirdre OMahoney and Franco Muggia
    12. Esophageal Cancer, Gauri Varadhachary and Jaffer Ajani
    13. Gastric Cancer, Manish A. Shah, Dana Rathkopf, and Gary K. Schwartz
    14. Gestational Trophoblastic Neoplasia, Michael M. Boyiadzis and John Lurain
    15. Head and Neck Cancers, Erin Donovan and Barbara Conley
    16. Hepatocellular Carcinoma, Joan Maurel and Jordi Bruix
    17. HIV-Related Malignancies, Pallavi Kumar and Richard F. Little
    18. Leukemia, Acute Lymphoblastic (Adult), Ivan Aksentijevich, Michael M. Boyiadzis, and Judith Karp
    19. Leukemia, Acute Myelogenous, Ivan Aksentijevich, Michael M. Boyiadzis, and Judith Karp
    20. Leukemia, Chronic Lymphocytic, Salah Abbasi and Bruce D. Cheson
    21. Leukemia, Chronic Myelogenous, Michael W.N. Deininger and Brian J. Druker
    22. Leukemia, Hairy Cell, Martin S. Tallman
    23. Lung Cancer, Enriqueta Felip and Rafael Rosell
    24. Lymphoma, Hodgkin, Christina M. Annunziata and Dan L. Longo
    25. Lymphoma, Non-Hodgkin, Kieron Dunleavy, David R. Kohler, and Wyndham H. Wilson
    26. Melanoma, Michael M. Boyiadzis and Barry Gause
    27. Mesothelioma, Verna Vanderpuye and Nicholas J. Vogelzang
    28. Multiple Myeloma, Robert Dean and Cynthia E. Dunbar
    29. Ovarian Cancer, Eddie Reed
    30. Pancreatic Cancer, Michael M. Boyiadzis and Daniel D. Von Hoff
    31. Pheochromocytoma, Michael M. Boyiadzis, Karel Pacak, and Tito Fojo
    32. Prostate Cancer, Peter F. Lebowitz and William L. Dabut
    33. Renal Cell Carcinoma, Michael M. Boyiadzis and Susan Bates
    34. Sarcomas, Janice Walshe, Tito Fojo, and Lee Helman
    35. Testicular Cancer, Michael M. Boyiadzis and Scott Saxman
    36. Thymic Carcinoma, Hanneke Wilmink and Guisseppe Giaconne
    37. Thyroid Cancer, Kenneth B. Ain
    38. Vaginal Cancer, Thomas Chen and Franco Muggia
    SECTION II:: SUPPORTIVE CARE, DRUG PREPARATION, COMPLICATIONS, AND SCREENING
    39. Chemotherapy-Induced Nausea and Vomiting:: Prophylaxis and Treatment, Thomas E. Hughes
    40. Drug Preparation and Administration, David R. Kohler
    41. Chemotherapy Dose Modifications, Michael Menefee, Pamela W. McDevitt, and Tito Fojo
    42. Antineoplastic Drugs:: Preventing and Managing Extravasation, David R. Kohler
    43. Indications for Growth Factors in the Hemotology-Oncology Setting, Pamela W. McDevitt and James N. Frame
    44. Indications for Bisphosphonates in the Hematology-Oncology Setting, Reem A. Shalabi, David R. Kohler, and James N. Frame
    45. Transfusion Therapy, Ashok Nambiar and Susan Leitman
    46. Oncologic Emergencies, Michael M. Boyiadzis and Tito Fojo
    47. Fever and Neutropenia, Juan Gea-Banacloche and Thomas J. Walsh
    48. Catheter-Related Bloodstream Infections:: Managing and Prevention, Naomi P. OGrady
    49. Venous Catheter-Related Thrombosis, McDonald Horne
    50. Complications and Follow-up After Hematopoietic Stem Cell Transplantation (HSCT), Michael M. Boyiadzis, Juan Gea-Banacloche, and Michael R. Bishop
    51. Radiation Complications, Diana Stripp and Eli Glatstein
    52. Cancer Pain:: Assessment and Management, Ann Berger
    53. Hospice Care and End-of-Life Issues, Charles F. Von Gunten and David Weismann
    54. Cancer Screening, Jennifer Eng-Wong, Kathleen Calzone, and Sheila A. Prindiville
    55. Genetics of Common Inherited Cancer Syndromes, Kathleen Calzone, Jennifer Eng-Wong, and Sheila A. Prindiville
    SECTION III:: SELECTED HEMATOLOGIC DISEASES
    56. von Willebrand Disease, Michael M. Boyiadzis and Margaret E. Rick
    57. Hemophilia, Steven J. Jubelirer
    58. The Hypercoagulable State, Jeffrey I. Zwicker and Kenneth A. Bauer
    59. Heparin-Induced Thrombocytopenia (HIT) and HIT with Thromboembolic Syndrome (HITTS), McDonald K. Horne, III
    60. Autoimmune Hemolytic Anemia, James N. Frame
    61. Sickle Cell Disease:: Acute Complications, James N. Frame, Steven J. Jubelirer, and Griffin P. Rodgers
    62. Aplastic Anemia, Michael M. Boyiadzis and Neal S. Young
    63. Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome (TTP/HUS), Kiarash Kojouri and James N. George
    64. Idiopathic Thrombocytopenic Purpura, Kiarash Kojouri and James N. George
    65. Polycythemia Vera, Celia L. Grosskreutz and Steven Fruchtman
    66. Essential Thrombocythemia, Celia L. Grosskreutz and Steven Fruchtman
    67. Myelodysplastic Syndromes, Michael M. Boyiadzis and Neal S. Young
Komentarze (0)